奥昔哌汀治疗迟发性运动障碍：一项为期8周的对照研究。
Oxypertine in tardive dyskinesia: an 8-week controlled study.
作者信息
Soni S D, Freeman H L, Hussein E M
出版信息
Br J Psychiatry. 1984 Jan;144:48-52. doi: 10.1192/bjp.144.1.48.
PMID:6140973
Abstract
In a double-blind placebo controlled trial of oxypertine in the treatment of tardive dyskinesia, 33 patients with chronic schizophrenia received either oxypertine or placebo. At the end of eight weeks, the results showed that oxypertine was superior to placebo at a statistically significant level.
摘要
在一项关于奥昔哌汀治疗迟发性运动障碍的双盲安慰剂对照试验中，33名慢性精神分裂症患者接受了奥昔哌汀或安慰剂治疗。八周结束时，结果显示奥昔哌汀在统计学显著水平上优于安慰剂。
Zotero 插件